Skip to main content
. 2019 Oct 22;9(10):e031305. doi: 10.1136/bmjopen-2019-031305

Table 2.

Participants’ knowledge-related responses

Variables n (% of participants)
Have you heard about clinical trials?
 Yes 289 (30.8)
 No/not sure 648 (69.1)
What is the definition of a clinical trial?
 Studies in clinics to survey patients’ opinions about healthcare topics 139 (14.8)
 Experiments on animals 119 (12.7)
 Studies to test new drugs or procedures on humans 410 (43.7)
 Graduation projects for medical students 62 (6.6)
 Not sure 208 (22.2)
Have you heard about an IRB?
 Yes 251 (26.8)
 No 685 (73.1)
Have you heard of the SFDA?
 Yes 761 (81.1)
 No 177 (18.9)
Does the SFDA play a role in regulating clinical trials?
 Yes 622 (66.4)
 No 315 (33.6)
Are there ethical guidelines to regulate the conduct of clinical trials?
 Yes 673 (71.8)
 No 265 (28.3)
Are there direct benefits for participants in clinical trials?
 Definitely 313 (33.4)
 Definitely not 35 (3.7)
 No benefit or harm 19 (2.0)
 Possible benefit or harm 436 (46.5)
 Not sure 135 (14.4)
Do clinical trials have direct benefits for the community?
 Yes 676 (72.1)
 No 262 (27.9)
When can an investigator start clinical trials?
 Any time they want 42 (4.5)
 Only with participant agreement 135 (14.4)
 After obtaining manager approval 41 (4.4)
 They should obtain approval from responsible authorities 525 (56.0)
 Not sure 195 (20.8)
Can an investigator recruit patients without their approval?
 Yes 250 (26.7)
 No 687 (73.3)
Can participants freely withdraw from clinical trials anytime?
 Yes 446 (47.6)
 No 492 (52.5)
May published articles include confidential patient information (eg, names)?
 Yes 318 (33.9)
 No 620 (66.1)
Knowledge score out of 100 (12 questions) 56.8± 24.8

IRB, Institutional Review Board; SFDA, Saudi Food and Drug Authority.